Priscilla Vilchis, fundadora y CEO de Premium Produce, es la primera latina en obtener una licencia para cultivar y producir cannabis medicinal en Nevada y California. Su planta de cultivo con tecnología de punta, Premium Produce, se encuentra a pocos kilómetros del nuevo estadio de los Raiders y de Las Vegas Strip, donde crece y empaca su marca de cannabis inspirada en sus raíces latinas, Reina.
Vilchis es pionera en la industria rompiendo varias barreras culturales y de género al tiempo que ataca los estereotipos de los consumidores de cannabis. “Ser pionera en este espacio también ayuda a allanar el camino para que otras mujeres y minorías se involucren”, dijo Vilchis a LA Weekly.
Su primer acercamiento con el mundo de cannabis fue a principio de sus veintes cuando una amiga fue diagnosticada con cáncer de mama en etapa III. Ella acompañaba a su amiga a sus quimioterapias y uno de sus doctores le sugirió el consumo de la marihuana para calmar el dolor después de cada tratamiento. Fue entonces que en solidaridad fumó marihuana por primera vez.
Vilchis no solo se enfrenta a la discriminación en ventas locales de hierba, sino que tiene que convencer a su propia comunidad para que cambie su percepción de la marihuana, que es una medicina y no una droga. Ella comenzó con su familia.
“Antes de ingresar a esta industria, tuve una larga discusión con mis padres y abuelos, que tradicionalmente son conservadores, y entienden que el cannabis es un medicamento para niños con epilepsia y dolor”, dijo Vilchis a Telemundo. “Apoyan plenamente los objetivos comerciales y mi misión de promover el cannabis como una alternativa a los opioides”.
Como muchos en la floreciente industria, Vilchis no comenzó con el cannabis. Se convirtió en empresaria a principios de sus 20 años como consultora de prácticas médicas, donde ayudó a los médicos a navegar las regulaciones y negociar con las compañías de seguros para tratar a pacientes que sufren lesiones ocupacionales.
A través de su trabajo en el cuidado de la salud, Vilchis vio de primera mano la creciente epidemia de opioides, que la impulsó a aprender sobre la marihuana medicinal como alternativa.
Ahora, Vilchis dice que espera poner el cannabis medicinal en manos de los médicos con los que trabajó en su carrera anterior.
“Mi objetivo es un día conseguir que la marihuana sea reembolsable en lugar de un opioide”, dijo. “Espero ser el frente y el centro de eso”.
The post La reina del Desierto Priscilla Vilchis, con paso fuerte en el mundo del cannabis. appeared first on High Times.
Hay muchas maneras de consumir cannabis, pero algunas son más fáciles de usar que otras. Ya sea que sea un nuevo usuario de marihuana medicinal o un nuevo usuario recreativo, las tinturas son un excelente lugar para comenzar su viaje de cannabis. ¿Qué es una tintura sin el cannabis? Son cualquier medicamento hecho al disolver una droga en alcohol. Repasaremos todo lo que necesita saber sobre una tintura de cannabis, incluida la forma en que se fabrican, usan y almacenan.
¿Qué es una tintura?
Las tinturas están hechas con un alto porcentaje de alcohol y vienen en botellas de vidrio con goteros. Como resultado, la tintura de cannabis es uno de los mejores métodos de consumo para una dosificación precisa.
El alcohol se usa para extraer terpenos y cannabinoides como el THC del resto del material vegetal. El cannabis utilizado debe descarboxilarse para garantizar que todos los ingredientes estén activos. De lo contrario, los efectos de la medicina no serán tan fuertes como podrían ser.
Similar a los comestibles, las tinturas se consumen por vía oral. De hecho, las tinturas se pueden usar por vía sublingual, oral o para infundir casi cualquier plato que desee. Lo mejor de todo, las tinturas son de acción más rápida que su típico comestible. Por lo tanto, no tendrá que esperar dos o tres horas solo para descubrir que su medicamento no funcionó. Debe poder saber, poco después de una dosis de tintura, si necesitará más o no.
A pesar de su conveniencia, rara vez se habla de tinturas de cannabis. Antes de la prohibición, era la forma más común de cannabis medicinal en los Estados Unidos.
Hoy, la mayor atención se dirige a otros métodos de consumo de cannabis, como fumar y al mercado de concentrado de cannabis que está en constante crecimiento. Sin embargo, el interés en formas alternativas de consumo ha estado creciendo en los últimos años. Como resultado, puede encontrar tinturas de cannabis en casi cualquier dispensario de marihuana medicinal en el país.
Cómo hacer una tintura de cannabis
Para hacer una tintura de cannabis, querrás tener el mayor porcentaje de alcohol posible. No todas las tinturas son iguales. La potencia del producto final dependerá de la calidad y cantidad del cannabis que use.
Ingredientes y equipamiento:
Como mínimo, querrás los siguientes ingredientes y equipos para hacer una tintura de cannabis:
Media onza de flores de cannabis.
Alto contenido de alcohol por volumen de licor.
tarro de albañil
Botellas cuentagotas de vidrio
Sartén a prueba de horno
Papel de aluminio
Vaso medidor de vidrio
Antes de comenzar, necesitará hierba o concentrados descarboxilados. Según una investigación de científicos en Holanda, la temperatura óptima para la descarboxilación es de 230 grados Fahrenheit durante 110 minutos.
Así que muele tu cannabis o rómpelo en trozos más pequeños y llena la sartén apta para horno con ellos. Cubra la sartén con papel de aluminio para que la hierba no se caliente lo suficiente como para quemar o vaporizar. Hornee en un horno que haya sido precalentado a 230 grados Fahrenheit durante 110 minutos.
Una vez que haya reunido los materiales necesarios, hacer una tintura de cannabis es fácil.
Paso 1: coloque su cannabis descarboxilado en el tarro de albañil y llénelo con el mayor porcentaje de alcohol como Everclear hasta que el cannabis esté completamente sumergido.
Paso 2: varias fuentes recomiendan congelar el frasco lleno de alcohol y cannabis durante varios días o dos semanas mientras lo sacas para agitarlo una vez al día. El frío ayuda a separar los componentes menos deseados de la planta de cannabis como la clorofila del producto final.
Paso 3: El siguiente paso es colar los materiales a través de una gasa en una taza medidora de vidrio. Una vez que el líquido ya no pase a través de la gasa, use guantes para exprimir el líquido restante a través de la gasa y dentro de la taza de medir. Puede usar otra gasa para limpiar el material aún más antes de llenar las botellas de vidrio con cuentagotas.
Paso 4: El último paso es almacenar adecuadamente su tintura. Transfiera todo a un frasco cuentagotas de vidrio para una fácil dosificación. Para el almacenamiento a largo plazo, puede dejarlo en un tarro de albañil. De cualquier manera, querrás que el ambiente sea fresco y oscuro. El aire, la luz y el calor disminuyen la calidad y la potencia de las tinturas.
Cómo usar tinturas de cannabis
Una vez que hayas hecho o comprado una tintura de cannabis, hay tres formas de usarla. Agréguelo a cualquier plato, colóquelo en su boca o ingiéralo por vía sublingual.
El método de consumo sublingual es uno de los mejores si desea sentir los efectos más fuertes y rápidos. Deje caer la dosis adecuada debajo de su lengua. Espere medio minuto y trague. Esto permite que el medicamento ingrese al torrente sanguíneo para un inicio más rápido.
La forma más fácil de usar una tintura de cannabis es simplemente colocando la dosis deseada en la boca y tragando. Los efectos no aparecerán tan rápido como con la técnica sublingual. Tardará casi tanto como lo haría con los comestibles para sentir los efectos.
El método final de consumo es relativamente simple. Coloque la dosis que desee en cualquier alimento o bebida que elija. La aparición de los efectos debería tomar tanto tiempo como los comestibles. Al consumir una comida con el medicamento, puede comenzar a combatir a los bocadillos incluso antes de que comiencen.
Razones para probar tinturas
Como hemos ilustrado, hay muchas ventajas al usar tinturas sobre otros métodos de consumo de cannabis. Aquí hay una lista de los beneficios de usar tinturas sobre otros métodos de consumo:
Menos calorías: puede obtener la experiencia comestible de las comidas que ya estaba planeando comer en lugar de dulces como gomitas y brownies.
Discreción: las tinturas no huelen a cannabis y en una botella de vidrio con un gotero, se verán como cualquier otra medicina.
Inicio más rápido: Sublingualmente, los efectos duran más.
Dosificación precisa: con comestibles, flores y concentrados, es más fácil tomar accidentalmente una dosis mayor de la necesaria. Las tinturas te permiten tomar unas gotas a la vez hasta que sientas los efectos deseados.
Más simple que fumar: las personas a las que no les gusta o les cuesta fumar o vapear cannabis se encuentran mejor usando tinturas.
Golpe final: tintura de cannabis
Las tinturas de cannabis ofrecen una manera simple y discreta de recibir los beneficios médicos de la planta sin tener que ser fumador. Solo se necesitan unos pocos ingredientes para hacer tinturas de cannabis, pero debes tener cuidado al prepararlos en casa porque un alto porcentaje de alcohol es inflamable. También hay dispositivos que facilitan completar todo el proceso en un solo lugar.
The post Tinturas de cannabis: todo lo que necesitas saber appeared first on High Times.
The highest court in Sweden has weighed in on the novel food, and the darling of the Swiss marketplace, CBD conversation. Further, it has done so in a move that seems predetermined to push the so-far escalating novel food debate EU-wide. Along, of course, with what constitutes “narcotic” cannabis.
Namely, Sweden’s highest court ruled in June that CBD oil with any concentration of THC falls under the narcotic jurisdiction.
Sound confusing? Welcome to the world of every CBD producer and purveyor on the “right” side of the Atlantic.
Beyond The Lingo and Legal Mumbo Jumbo
When one follows the logic, there is one, hidden in the Swedish meatball of careful legal wording. Here is a translation, more or less of what the court intended.
The first is that the Swedes, along with the Italians (and expect this attitude to be reflected all over Europe) accept that cannabidiol when it comes from hemp, if not CBD oil derived from the same, generally, is excluded from the definition of cannabis (as a narcotic). Therefore it is not a narcotic drug.
However, according to the court, the loose definitions of what “CBD oil” is both legally and in the marketplace, no longer applies if the plant has been converted into a preparation containing THC. This is a clear shot across the bow of the “Cannabis Lite” movement that has been so popular across the continent for the last year or so and has absolutely electrified certain regions (see not only Switzerland but the UK and Spain).
This has added to the sky-high evaluations of the cannabis industry (or even the CBD part of it) in certain industry predictions, rosy scenarios and forward-looking statements.
However, in a nod to reality, the court also recognized that there is an exemption for trace amounts of CBD in the current frameworks, although it is indeterminate. In other words, this is a move to force regulators to determine what trace levels of THC are permitted. And further, to force regulation and licencing of the so-far, fairly free-wheeling industry that hoped, much like Holland, to establish itself in the grey spaces between the regulatory schematic of Europe.
No dice. See Holland of late. But also see Italy, Austria and Germany.
For those who still held out a vague dream of hope that this whole issue was going to go away, or get swept under the carpet of anti-regulatory Brexit mania (in the British case), think again.
In the Swedish situation, much like the Italian CBD caper, the individual at the heart of the court case was a man who escaped a minor drug charge for possession of CBD oil. However, the message is clear: Large scale distribution of CBD oil with “undeterminable” levels of THC (essentially all of it in the market until the rules are set), is courting a criminal drugs charge.
Look for licensing definitions soon.
What Does This Say About The CBD Future In Europe?
Much of this debate is also caught up in larger issues, namely labelling. The British, for example, have just seen recalls at some of the largest supermarkets in the country because of the same. It is a hot topic in several places.
Europeans, in general, and this includes the British, are generally also horrified at how Americans in particular, consume food and other products exposed to chemicals they know are toxic. However common chlorinated chicken is in the U.S., for example, this is a discussion as toxic to all Europeans, including the British, as well, chemically treated anything.
This is also a reflection of the much “greener” lifestyle Europeans aspire to lead (even with bizarre gross-outs like “fatbergs” in the Victorian recesses of London sewers). Even if they have not managed it yet, here. Climate change denial, especially in mostly air-conditioner free Europe, and especially this summer, is a rare concept indeed.
The novel food issue where it crosses with cannabis, in other words, has just popped up again, in Sweden. And given its proximity to not only recent legal decisions on the same, especially by their neighbors, if not on the calendar, the industry and all those who hope to chart its projections if not successfully surf its market vagaries, need to take note if not adjust accordingly.
The post Sweden Joins Italy In Path To Defining CBD Oil Regulations appeared first on Cannabis Industry Journal.
In late June, as more than a thousand people descended on the South Bank Center to attend the largest cannabis conference held so far in the UK, another development was taking place away from the headlines.
Drug Science, a non-profit research group founded to reform drug policies based on scientific evidence rather than politics or even economic considerations, launched an ambitious trial project in the UK.
The goal? To get medical cannabis to 20,000 British patients suffering from a range of conditions that the drug is well known to help treat.
Who Is Drug Science?
Founded by Professor David Nutt, the former chief drug advisor to the British government who was fired in 2009 for stating that ecstasy and LSD were less harmful than alcohol, the group itself is clearly not afraid to tackle controversy. The Project TWENTY21 initiative is an ambitious if not desperately needed undertaking.
Targeted patient groups include those suffering from chronic pain, PTSD, MS, Tourette’s and addiction.
Several cannabis companies have already signed up to support the effort which also includes the United Patients Alliance ,and academic researchers.
According to Abby Hughes, Head of Outreach for UPA, “Whilst a change in UK law has given clinicians the green light to prescribe medical cannabis, the majority of patients are denied access, some even being criminalised, whilst corporations are profiting from the same plant.”
Hughes also noted that the goal of the project is to begin to ground patient demand in research and hard data. “We hope that by having a dataset that proves the efficacy of medical cannabis, thousands of patients will be able to access legal, affordable medicine, which may improve their quality of life,” she said.
What Is The Scope of Project TWENTY21?
It is the first-of-its-kind project in the UK where, 9 months after the law changed to allow prescription of cannabinoids as well as the medical importation of the same, there are less than 20 (legal) patients in the country. And all of the successful candidates so far have fought for the right and still do.
While important in its own right, the concept if not forward motion on the same, is also poised to create similar trials all over Europe. This is especially true in countries (like France) where the issue of reform has not moved at all. Or even in Germany (with well over 50,000 patients two and a half years after similar reform was passed by the Bundestag) where problems with access and questions about medical efficacy still frustrate the close to a million Germans who cannot access the drug. Switzerland and Luxembourg may yet prove to be similiarly interesting.
Why Is This Timely?
There has been an increased call for the need for widespread and sustained population trials across Europe as the cannabis industry has really begun to establish itself since mid-2016. This is the only way to help forward medical understanding of cannabinoids at a level that leads to mainstream acceptance. And more importantly, medical and payer mainstream approvals. Until that happens, despite all the press releases, overall sales across the continent remain low.
One of the most important issues beyond this – the extraordinarily high pricing seen in Europe until late last year – has also played a role of course. Payers (see the German “statutory” health insurers) on the front lines of uncertain medical efficacy are still reluctant to pay for a drug, in any form, they do not understand, do not have evidence for, and are still highly suspicious of.
There has been an increased call for the need for widespread and sustained population trials across Europe With cannabis companies agreeing to provide product (in this case potentially from Australia), a research organization with national chops and brave leaders is likely to take the conversation far. And not just in the UK.
While Drug Science is of course not the only British entity planning canna trials and in part supported by the Canadian industry (see The Beckley Foundation for starters), Project 2021 is also certainly likely to be a study with both local as well as regional and global implications.
In Europe, there are other regional trials now in the offing (see Switzerland, Germany and France). Only Germany of course, has a patient population that is starting to be large enough to be effectively studied, and of course, the majority of these patients are still receiving dronabinol.
It is also clearly a steady state march, rather than a discussion that is likely to see significant boosts in patient numbers any time soon. Unless of course, there are other contributing factors.
Regardless, unlike the U.S. and even Canada, the strict medical focus of Europe (including the UK) is finally moving the conversation to the next level. Large, regional and/or national medical trials – and further for conditions the drug is well-known to treat but are so far considered “off-label” for most Europeans will be the watchword here for the next several years.
The post UK Non-Profit Launches Project TWENTY21 To Register 20K Cannabis Patients appeared first on Cannabis Industry Journal.
A potentially explosive report detailing the distribution of pharmaceutical opiates reveals a disturbing connection between Utah’s anti-medical cannabis movement and the pharmaceutical industry. Specifically, one of the state’s leading anti-legalization policymakers is also one of the state’s biggest seller of opiates.
The revelation has sparked outrage among medical marijuana patients and advocates, and has intensified ongoing tensions surrounding Utah’s controversial medical marijuana laws.
New Stats About Opiates Made Public
Recently, the Washington Post released a trove of federal data related to the distribution of pharmaceutical opiates across the country. Specifically, the searchable database tracks who is selling opiates and how much they’re selling.
The stats unveil a number of problematic trends. For starters, the database shows that the country’s pharmaceutical companies have sold 76 billion oxycodone and hydrocodone pills between 2006 and 2012. During that same time period, roughly 100,000 people have died from complications related to opiates and opiate addiction.
Additionally, the publication of the database has spurred in-depth searches and analyses, one of which found that Utah Senate Majority Leader—and top anti-cannabis lawmaker—Evan Vickers is one of the state’s biggest sellers of opiates.
As a result, legalization advocates are calling foul. And some of Utah’s top activists are demanding that Vickers recuse himself from all legislation related to marijuana.
“When we saw the outrageous numbers of opiates that Vickers is dispensing, it was alarming to all of us,” Christine Stenquist, Founder and Executive Director of Together for Responsible Use and Cannabis Education (TRUCE), told High Times. “Even more alarming is that this man is trying to prohibit cannabis from coming into the state. And we’ve seen in states where there is cannabis, that there’s a decline in pharmaceuticals, especially opiates.”
Vickers: Leading Opiate Seller and Anti-Cannabis Lawmaker
According to researcher and writer Angela Bacca, Vickers, who owns a chain of pharmacies in southern Utah, distributes 34 percent of all opiates in Utah’s rural Iron County. Vickers’ two Cedar City pharmacies sell even more opiates than massive national chains like Wal-Mart.
For many medical marijuana advocates in Utah, the sheer number of opiates sold by Vickers is alarming enough. But to make things even worse, it turns out that Vickers has been a leading voice in the fight against medical marijuana in Utah.
Specifically, he was the sponsor of the controversial H.B. 3001. This medical marijuana bill was rammed through in a special legislative session in December 2018, just two days after a voter-approved initiative went into effect.
In 2018, a medical marijuana bill called Proposition 2 qualified for the ballot. But long before voters had a chance to vote, powerful forces in Utah began working against Proposition 2.
Specifically, the Church of Jesus Christ of Latter-Day Saints, also known as the Mormon Church or the LDS Church. For starters, the church formally opposed the initiative. Further, church leaders sent a letter to members urging them to vote no. Given that roughly 62 percent of Utahns—including the huge majority of lawmakers—are Mormon, the LDS Church has significant political sway.
Alongside publicly speaking out against Proposition 2, Mormon Church representatives began meeting with lawmakers to draft a “compromise bill,” which ultimately became H.B. 3001. And Vickers was the bill’s floor sponsor.
“They’ve put up roadblocks, excuses, and weak-kneed legislation,” Stenquist told High Times. “Policymakers have made very confusing policy and it’s just not where we need it to be. And I believe it’s special interests that drive our policies. What I’m concerned about is that special interests are making profit at the expense of our communities.”
Utah’s Medical Marijuana Controversy: The Newest Chapter
H.B. 3001 has drawn significant backlash from medical marijuana patients and activists. For starters, TRUCE and other medical marijuana advocates have filed a lawsuit against the state.
Among other things, the suit claims that the Mormon Church exerted unlawful influence over the lawmaking process, culminating in the quick replacement of the voter-approved Proposition 2.
Additionally, many advocates say that H.B. 3001 is far too restrictive. In particular, according to Stenquist, it limits the number of dispensaries and the number of patients to whom a doctor can recommend medical marijuana.
“Vickers is behind this restrictiveness for patients,” Stenquist told High Times. “This is all motivated because Vickers is protecting his bottom line. This is a clear conflict of interest. Special interest legislators like Vickers are writing policies that better their particular industry and put money in their own pockets. That has to stop.”
She added: “We need to lower our dependency on pharmaceutical drugs and cannabis is one of the tools that can do that. But Vickers does not want to harm his bottom line.”
In light of the news about Vickers’ opiate activities, Stenquist is calling on him to recuse himself from all marijuana-related legislation. It is unclear what, if any, legal action TRUCE or other groups may pursue. But for now, the suit filed earlier this year remains ongoing.
The post Utah’s Top Anti-Cannabis Lawmaker is Also One of the State’s Largest Opiate Sellers appeared first on High Times.
This article originally appeared in the April 2019 issue. For subscription services, click here.
The art of consuming concentrates has undergone several evolutions over the years. Each advancement in dabbing has improved the efficiency of the experience, leading to more flavorful dabs as well as a more convenient cleanup. This evolution is probably best illustrated by the massive shift that occurred when connoisseurs first stepped away from hot dabs off of metal nails and moved on to new techniques in the quest for flavor.
When the first amber-colored extracts surfaced, concentrate fans were happy just to have a way to consume them—even if it meant using a harsh red-hot knife. The hot-knife concept was the basis for the first bongs made for concentrate consumption. These were made with skillets, which were like hot plates directly under a tube that filtered vapors through water for cooler, larger hits.
The next innovation in concentrate consumption represented a step forward and two steps back. It was a nail that fit into male joints with a borosilicate globe or dome around it to partially keep the vapor from escaping. This required glass water pipes to be made with male joints for the first time.
Additionally, the dome would have to be removed before each dab, and it would sometimes get stuck once oil built up in the joint. Thanks to the mess and extra steps it required, it didn’t take long for domes and nails to be replaced by the simplified, all-in-one domeless nail.
This is when the transition to lower-temperature dabs for flavor and comfort began. People started to let their domeless nails cool for some time after heating them up, which made hits less harsh. The carb cap was then introduced to allow vaporization to occur at a lower temperature for smoother, tastier dabs. Caps helped reduce the size of puddles left behind on the nail without compromising on flavor.
Another step in the quest for better-tasting dabs was the introduction of quartz in place of titanium and ceramic nails. On top of improving flavor, quartz nails provided an easier-to-clean surface.
Another major shift occurred when the glass artist Quave took the nail design a step further by introducing the quartz club banger (see photo)—the shape made it easy to insert a Q-tip inside for smoother cleanups, and it retained heat for longer-lasting low-temperature dabs. The quartz club banger’s top (the bucket) was cut at a 45-degree angle, inspiring tons of copycats for some time before the next step in the evolution of low-temperature dabbing—the thermal banger.
Pukinbeagle Glass introduced us to the thermal banger with a jacketed design. It was the first such device that used a bucket within a bucket. Thermal bangers also introduced us to the concept of flat tops and bubble caps.
While popular, this design had a flaw: Oil could leak between the two layers of quartz (the bucket within a bucket). Fortunately, quartz makers took the advantages of the thermal banger and tweaked the design. As a result, most bangers today feature flat tops without the jacketed design, and most dabbers use bubble caps.
Now most low-temperature dabs are dropped after heating all around the bucket of a quartz banger for close to a minute and after another minute or longer for things to cool down. The temperature starts high and rapidly decreases after the extract is dropped and vaporizes.
The ideal temperature for a full-flavored dab can range from 350 to 500°F. Unfortunately, most bangers don’t have the heat retention to stay in that range for long enough to completely vaporize a dab. As a result, puddles containing leftover terps and THC can be left behind, especially after big globs. Reheating the puddle to completion usually results in a harsh, flavorless hit. Even with a carb cap, you’ll usually end up sacrificing some of your concentrate with low-temp dabbing.
To completely finish a dab in one go, you’d have to drop the oil in earlier while the nail is hotter. That sounds reasonable; however, the problem is that THC boils off at 315°F, and most terpenes boil off at a much lower temperature than that. To finish a dab, you would be dropping it in while the nail is well over 500°F.
In addition to the harshness of dabbing at such high temperatures, a lot of your terpenes and cannabinoids will be scorched before they can add to the flavor and potency of your dab. Not to mention that research from Portland State University published in the journal ACS Omega found that dabbing at temperatures above 600°F could result in the release of noxious chemicals.
Fortunately, the latest step in the evolution of dabbing resolves this issue. Cold starts are like reverse dabs. Instead of getting a surface raging hot and waiting to drop the hash in, the extract is added to the surface while it’s still cold. The temperature is then gradually increased. This practice prevents waste while preserving flavor, time and butane with the proper tools. It’s a simple but effective method, and more and more products are being made with this concept in mind.
Taking some inspiration from the inner bucket of the Pukinbeagle thermal design, Eternal Quartz made a removable quartz bucket so it could be cleaned or used on different bangers. Shortly after creating these “quartz inserts,” the company started experimenting with different ways of taking “meltshot” videos. That’s when Eternal first tried out the “insert drop” technique and cold-start dabbing commenced.
The insert-drop method allows the temperature of the concentrate within the quartz insert to slowly increase as heat transfers from the outer layer of the heated banger. This causes vapor production to last longer than it would with traditional low-temperature dabs.
To do a cold-start dab with an insert, you need to put your hash in the insert and set it aside. Heat the bucket of your banger as you normally would and, after waiting a bit, drop in the insert. The wait time depends on the size of your dab and the heat retention of your banger. It can be anywhere from five to 40 seconds. On your final pull, the oil should be much darker and tackier than when it started.
After Eternal Quartz got things started for cold-start dabbing, other companies took the idea and ran with it. Riding the cold-start wave, OG Quartz created a banger design with an eye on convenience. The OG Quartz banger’s walls are three millimeters thick with a wide and curvy bottom that is easier to Q-tip than any other banger on the market. You’ll need a cap from OG as well. The inner wall of the flat top and the carb caps designed for the banger are tapered for proper seals. The stem reaches deep into the banger with a 45-degree cut at the end, which allows airflow to tornado through, constantly spinning the oil around the bottom of the bucket.
The carb cap’s wide diameter, combined with the bucket’s shorter diameter, thick walls, curved sides and dense bottom, allow for heat to transfer slowly enough through the banger to provide flavor without burning.
To do a cold start with an OG Quartz banger, you can either load your hash onto the end of the carb cap or onto the bottom of the bucket. Depending on the type of extract you’re using (less heat for rosin, more for THCA crystals) and the strength of your torch, you’ll need to heat the bottom of the banger for about five to eight seconds before the first hit. The oil should begin to bubble and vaporize when you inhale.
The cap is designed to be cleared like the bongs OG Quartz has been making for 22 years—well before dab rigs were a thing. When vapor stops forming, there might still be a puddle. After the initial hit, you can provide three-to-five-second bursts of heat to finish off the remainder. This method will save the dabbing community tons on butane as it only takes 15 to 20 seconds of heating to finish an entire dab. With the proper amount of torching, you should get all the flavor and potency in the extract without any burning.
The concept of cold starts is improving the world of electronic vaporizers for concentrates as well. In fact, the Peak by Puffco takes advantage of cold starts for flavorful dabs, as the device works best when concentrates are preloaded into the ceramic cup before the atomizer is fired. As heat is transferred into the cup, hash oil goes from cold to hot so you can enjoy all of the terpenes that boil off along the way. If there is anything worth vaping left behind, you can hit the boost setting or reheat the puddle on a lower setting to finish it off without any burning.
Every time we think we’ve found the best method of consumption, a new innovation arrives and changes the game. Cold starts are the latest step, but there will doubtless be a new technique that improves consumption as we continue on our journey to the perfect dab.
If you taste burning oil and everything on the banger is too dried up to be easily Q-tipped, you dropped your dab in while the bucket was too hot. However, if you’re not getting much vaporization and a huge puddle is left behind after your dab, you waited too long. Experiment to find the perfect-temperature dab.
While insert drops provide some of the most rewarding dabs in terms of flavor and vapor production in one heat-up, there are additional steps and tools involved with cleanup. It helps to have reverse tweezers, a shot glass full of isopropyl alcohol and paper towels on hand to get the job done quickly.
The post The Quest for the Perfect Dab appeared first on High Times.
There are growing calls in the United Kingdom to legalize recreational marijuana, with parliamentary officials even suggesting that it could be done in the next five years. But some people apparently aren’t willing to wait that long.
A pair of individuals, both clad in black masks, were filmed in Manchester this month doling out free cannabis to passersby. The video shows the two in Piccadilly Gardens, one of the city’s major green spaces, unfurling a sign that makes it abundantly clear what they set out to do: “FREE BUD ‘SOUVENIRS.’” The duration of the footage plays out as you would expect, with the masked individuals — donning black attire from head to toe — pulling out one marijuana bud after another to an ever-swelling group of park-goers.
The two individuals reportedly passed out £800 (about $980) worth of free marijuana. Video of the stunt surfaced online Monday, but according to Lad Bible, it was shot on July 14. “One of the two pot peddlers, however, was intercepted by police and arrested as they headed home,” Metro reported. The other individual involved, identified only as “Outlaw,” told Metro that he successfully evaded authorities.
“‘You can’t arrest a character with a made up name and no face. Outlaw’s lawyers are right on top of the game,” the anonymous individual said, adding that the free pot-giveaway was “literally just the start.”
“We question UK laws and legislation and like to test the authority,” Outlaw told Metro. “Until somebody can convince us that there’s a legitimate reason for cannabis to be illegal, we’ll keep doing what we’re doing and keep pushing the barrier, regardless of the law.”
There are some lawmakers in Britain who share that view. A group of members of parliament recently returned from a fact-finding mission in Canada to Great Britain with a bullish outlook for the legalization movement in Britain, where marijuana is still classified as a “Class B” drug, making possession, cultivation, and distribution illegal. Two MPs who participated in the trip to Canada, David Lammy of the Labour party and the Lib Dem Norman Lamb, both predicted that marijuana would be available to purchase legally in the UK in the next five years. Medical cannabis was made legal in Great Britain last year, but its rollout has been marred by restrictions that have made the treatment unattainable for many would-be patients.
Lammy, a legalization advocate, laid out what his vision for a legitimate marijuana market in Britain.
“I want the market legalised, regulated and taken away from crime gangs,” Lammy said, as quoted by Metro. “‘I want to see the strength of the stuff reduced, labelled, and properly organised in this country.”
The post Masked Activists Hand Out Nearly $1000 Worth of Cannabis in Manchester appeared first on High Times.